Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology/Infectious Diseases
Clinical Trials: HIV
A listing of clinical trials currently looking for volunteers to enroll in HIV studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Community Care Building
Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daily Valacyclovir in the Reduction of HSV-2 Recurrence and Viral Shedding
California
Duarte : City of Hope Updated
A Pilot Study of Safety and Feasibility of Stem Cell Therapy for Aids Lymphoma Using Stem Cells Treated with a Lentivirus Vector-Encoding Multiple Anti-HIV RNAs
Duarte : City of Hope Updated
Pilot Survey of Outcome in Patients with HIV Related Lymphomas by Analysis of CCR5 Genotype, HIV Infection Status, and Immunity to Selected Tumor Markers
Los Angeles : Charles R. Drew University - Clinical Research Center
Testosterone Replacement and Physical Function in HIV-Associated Weight Loss.
View More »
Newport Beach : Orange Coast Medical Group
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
San Diego : UCSD Antiviral Research Center
Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals
San Francisco : Quest Clinical Research
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
San Francisco : San Francisco VA Medical Center
High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease
Connecticut
Norwalk : Circle CARE Center, LLC
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Florida
Daytona Beach : Updated
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Miami : Updated
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Miami Beach : Wohlfeiler, Piperato and Associates, LLC
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Orlando : Orlando Immunology Center
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Port Saint Lucie : Updated
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
View More »
West Palm Beach : Updated
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Illinois
Elgin : Sherman Health
ECOG E4A08:Ph III Melphalan, Dexamethasone + Bortezomib Untx systemic light-chain amyloidosis.
Kentucky
Lexington : University of Kentucky Chandler Medical Center
HIV Positive Infected Patients Needed For an Observational Study of The Safety of MARAVIROC
Massachusetts
Boston : Fenway Health Updated
Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV
Missouri
Saint Louis : Washington University in St. Louis - Center for Clinical Studies
Young adults, 18 - 24 years of age, are needed for a research study.
View More »
St Louis : Central West Clinical Research, Inc.
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
New Mexico
Santa Fe : Southwest CARE Center
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
New York
Bronx : Biomedical Research Alliance of New York
HIV - Adults
Bronx : Biomedical Research Alliance of New York
HIV-Infected Adults
Brooklyn : Biomedical Research Alliance of New York
HIV-1
Manhasset : Biomedical Research Alliance of New York
Clinical trial to test how well study drug is tolerated in HIV-1 infected individuals.
Manhasset : Biomedical Research Alliance of New York
HIV and Renal Impairment
Manhasset : Biomedical Research Alliance of New York
HIV-1 Virus Infection - Adults
View More »
Bronx : Updated
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
New York : Ricky K Hsu, MD, PC
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Syracuse : Suny Upstate Medical University
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
North Carolina
Chapel Hill : Updated
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Ohio
Cincinnati : University of Cincinnati
The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
Texas
Houston : Gordon Crofoot, MD, PA
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Houston : Thomas Street Health Center-HCHD
Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy
Houston : The University of Texas Health Science Center at Houston
Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP)
Washington
Argentina
Buenos Aires, Bs As : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Australia
Adelaide : O'Brien Street Practice
Maraviroc Switch Collaborative Study
Bisbane : Gladstone Road Medical Centre
Maraviroc Switch Collaborative Study
Sydney : Holdsworth House Medical Practice
Maraviroc Switch Collaborative Study
Sydney : East Sydney Doctors
Maraviroc Switch Collaborative Study
Sydney : St. Vincent's Hospital
Maraviroc Switch Collaborative Study
View More »
Sydney : Taylor Square Private Clinic
Maraviroc Switch Collaborative Study
Sydney : St Vincent Hospital, Clinical Research Program
Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.
Sydney : Holdsworth House Medical Practice
Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.
Brazil
Porto Alegre : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Recife : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Ribeirao Preto : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Sao Paolo : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Burkina Faso
Bobo Dioulasso : Day Hospital, CHU Sanou Souro
Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
Cameroon
Yaounde : Day Hospital, Central Hospital
Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
Canada
Montreal : Montreal Chest Institute
Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection
Chile
Santiago : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
China
Beijing : Division of Treatment and Care, NCAIDS, China CDC
A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance
Germany
Aachen : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Berlin : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Bochum : University Hospital of Bochum, Department of Dermatology
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up
Dortmund : HIV Outpatient Department
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up
Dusseldorf : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
View More »
Essen : University Hospital, Department of Dermatology and Venerology
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up
Essen : University Hospital, West German Heart Center Essen
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up
Frankfurt/Main : HIV Treatment & Research Unit, Dept. of Internal Medicine II, Hospital of the Johann Wolfgang Goethe University Frankfurt/Main
A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients
Freiburg : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Hamburg : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Hannover : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Munchen : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Regensburg : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Stuttgart : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Italy
Milano : San Raffaele Scientific Institute
Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders
Varese : Ospedale di Circolo and Fondazione Macchi
Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients
Mexico
Guadalajara : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Merida : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Oaxaca : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Poland
Warszawa : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Portugal
Aveiro : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Puerto Rico
Rio Piedras : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
San Juan : Clinical Research Puerto Rico
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
San Juan : Fundacion de Investigacion de Diego
Drug Interaction Study of PSI-7977 and Antiretroviral Therapy(ART) Combinations in Human Immunodeficiency Virus and Hepatitis C Virus (HIV/HCV) Co-infected Patients.
San Juan Pr : Updated
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women
Russian Federation
Senegal
Dakar : Clinical Research and Training Center, Fann Hospital
Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
South Africa
Benoni : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Bloemfontein : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Johannesbourg : Helen Joseph Hospital-Themba Lethu Clinic
Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders
Parrow Valley : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Pretoria : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
View More »
Soweto : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Spain
Badalona : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Barcelona : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Barcelona : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Granada : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Guadalajara : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
View More »
Leganes : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Logrono : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Madrid : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Madrid : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Malaga : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Marbella : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Mataro : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Mostoles : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Santiago de Compostela : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Sevilla : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Tarragona : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Valencia : Local Institution
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
United Kingdom
Birmingham : Local Institution
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Guildford : Surrey Clinical Research Centre University of Surrey
EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine
London : Imperial College Healthcare NHS Trust
The Rilpivirine Cerebrospinal-fluid (CSF) Study
United States
Washington : Children'S National Medical Center
Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
